Literature DB >> 22289247

Prevalence of anatomic impediments to interlaminar lumbar epidural steroid injection.

Farah Hameed1, David J Hunter, James Rainville, Ling Li, Pradeep Suri.   

Abstract

OBJECTIVE: To determine the prevalence of anatomic impediments to interlaminar lumbar epidural steroid injection (LESI) in a community-based population.
DESIGN: Cross-sectional observational study.
SETTING: Community-based. PARTICIPANTS: Older adults (N=333) sampled irrespective of back pain status.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Computed tomography evaluation of 5 potential anatomic impediments to interlaminar LESI at the L2-S1 spinal levels, including (1) ligamentum flavum (LF) calcification, (2) interspinous ligament (ISL) calcification, (3) spinous process (SP) contact, (4) the absence of epidural fat in the posterior epidural space, and (5) the presence of fat density superficial to the LF in the midsagittal plane. Independent variables included age, sex, body mass index (BMI), and current smoking.
RESULTS: LF and ISL calcifications were prevalent in 3% to 7% and 2% to 3% of spinal levels, respectively, without significant differences by spinal level. SP contact was most common at the L4-5 level (22%). Absence of posterior epidural fat was very common at L5-S1 (65%), but infrequent at other levels. The presence of midline fat density superficial to LF was most common at L5-S1 (55%). The prevalence of LF calcification, ISL calcification, and SP contact increased with age, but the prevalence of absence of posterior epidural fat and the presence of a midline fat density superficial to LF did not. Sex and smoking status were not associated with the prevalence of anatomic impediments, but higher BMI was associated with a lower prevalence of absence of posterior epidural fat.
CONCLUSIONS: Anatomic impediments to interlaminar LESI were common in this community-based population, particularly at the L5-S1 spinal level. Because of the high overall prevalence of anatomic impediments, and differences in prevalence by spinal level, knowledge of the distribution and frequency of these impediments may aid in aspects of decision-making for the interventional spine physician.
Copyright © 2012 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22289247      PMCID: PMC3567928          DOI: 10.1016/j.apmr.2011.08.024

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  17 in total

1.  The Framingham Offspring Study. Design and preliminary data.

Authors:  M Feinleib; W B Kannel; R J Garrison; P M McNamara; W P Castelli
Journal:  Prev Med       Date:  1975-12       Impact factor: 4.018

2.  Corticosteroid infiltration of the extradural space.

Authors:  P J BARRY; P H KENDALL
Journal:  Ann Phys Med       Date:  1962-05

3.  Evidence for lower variability of coronary artery calcium mineral mass measurements by multi-detector computed tomography in a community-based cohort--consequences for progression studies.

Authors:  Udo Hoffmann; Uwe Siebert; Arabella Bull-Stewart; Stephan Achenbach; Maros Ferencik; Fabian Moselewski; Thomas J Brady; Joseph M Massaro; Christopher J O'Donnell
Journal:  Eur J Radiol       Date:  2006-01-24       Impact factor: 3.528

4.  The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination.

Authors:  Greta Lee Splansky; Diane Corey; Qiong Yang; Larry D Atwood; L Adrienne Cupples; Emelia J Benjamin; Ralph B D'Agostino; Caroline S Fox; Martin G Larson; Joanne M Murabito; Christopher J O'Donnell; Ramachandran S Vasan; Philip A Wolf; Daniel Levy
Journal:  Am J Epidemiol       Date:  2007-03-19       Impact factor: 4.897

5.  Analysis of the growth of epidural injections and costs in the Medicare population: a comparative evaluation of 1997, 2002, and 2006 data.

Authors:  Laxmaiah Manchikanti; Vidyasagar Pampati; Mark V Boswell; Howard S Smith; Joshua A Hirsch
Journal:  Pain Physician       Date:  2010 May-Jun       Impact factor: 4.965

6.  Epidural steroids for treating "failed back surgery syndrome": is fluoroscopy really necessary?

Authors:  B Fredman; M B Nun; E Zohar; G Iraqi; M Shapiro; R Gepstein; R Jedeikin
Journal:  Anesth Analg       Date:  1999-02       Impact factor: 5.108

7.  Epidural injections for the diagnosis and treatment of low-back pain.

Authors:  A H White; R Derby; G Wynne
Journal:  Spine (Phila Pa 1976)       Date:  1980 Jan-Feb       Impact factor: 3.468

8.  Parental occurrence of premature cardiovascular disease predicts increased coronary artery and abdominal aortic calcification in the Framingham Offspring and Third Generation cohorts.

Authors:  Nisha I Parikh; Shih-Jen Hwang; Martin G Larson; L Adrienne Cupples; Caroline S Fox; Emily S Manders; Joanne M Murabito; Joseph M Massaro; Udo Hoffmann; Christopher J O'Donnell
Journal:  Circulation       Date:  2007-09-04       Impact factor: 29.690

9.  Facet orientation and tropism: associations with spondylolysis.

Authors:  Leonid Kalichman; Ali Guermazi; Ling Li; David J Hunter; Pradeep Suri
Journal:  J Spinal Disord Tech       Date:  2010-04

10.  Analysis of growth of interventional techniques in managing chronic pain in the Medicare population: a 10-year evaluation from 1997 to 2006.

Authors:  Laxmaiah Manchikanti; Vijay Singh; Vidyasagar Pampati; Howard S Smith; Joshua A Hirsch
Journal:  Pain Physician       Date:  2009 Jan-Feb       Impact factor: 4.965

View more
  2 in total

1.  Radiation dose reduction in CT fluoroscopy-guided lumbar interlaminar epidural steroid injection by minimizing preliminary planning imaging.

Authors:  Nam Chull Paik
Journal:  Eur Radiol       Date:  2014-06-04       Impact factor: 5.315

2.  Short-term results of intrathecal injection of low-dose bupivacaine in outpatients with chronic low back and lower extremity pain.

Authors:  Akifumi Kanai; Takashi Okamoto; Norihito Hayashi; Junko Shimao; Yuki Nagahara; Kaoru Fujii
Journal:  Eur Spine J       Date:  2018-10-26       Impact factor: 3.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.